What is the Latest in Preventing Cancer?
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
Category: AACR
Guest Post by Scott M. Lippman, MD UC San Diego Moores Cancer Center
Sara Hanna Velarde, PhD, began her career in cancer research as a graduate student at the University of North...
Last year saw significant progress against lung cancer, with seven new therapeutics, including two immunotherapeutics, approved by the U.S....
It’s that time of year when we reflect on the progress we made over the past 12 months –...
During this holiday season, the AACR Foundation, like many other nonprofit organizations, administers its end-of-year appeal campaign. We urge...
This year has been a momentous year in healthcare, and, as some news outlets like Boston’s WBUR radio are...
On Nov. 16, 2015, the AACR hosted several dozen patient advocates and executives from leading pharmaceutical companies, as well...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new anticancer therapeutics continued last week when...
Breast cancer researchers are packed up in San Antonio, eager to build on the latest information they gathered at...
Breast cancer recurrence rates were similar for postmenopausal women with estrogen receptor-positive DCIS whether they took anastrozole or tamoxifen,...